For instance, high levels of proximity between PD-L1+ cells and either PD-1+ cells (25, 62, 63), exhausted CD8+ cells (64), or cancer cells (65) have been associated with improved outcomes after ICB therapy. This evidence concerns the gene CD8A and cancer.